Skip to main content

Advertisement

SpringerLink
Log in

Probucol

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

The purpose of this review article is twofold. It seeks to present an overview of research studies conducted on the many effects of probucol, and it demonstrates the interest in pursuing studies on probucol’s multiple specific actions and its future as a therapeutic agent. Within this article, the results of animal studies, experimental human studies, and clinical human studies are detailed, as is information on toxicology studies and on the side effects of the drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Davignon J: Pleiotropic effects of drugs affecting lipid metabolism. Newsletter of the International Atherosclerosis Society, 1999:2.

  2. Inouye M, Hashimoto H, Abo K, et al.: The effect of probucol on oxidized cholesterol disposition in hyperlipidaemic patients. J Intern Med Res 1998, 26:233–238.

    CAS  Google Scholar 

  3. Plump A, Masucci-Magoulas L, Bruce C, et al.: Increased atherosclerosis in apoe and ldl receptor gene knock-out mice as a result of human cholesterol ester transfer protein transgene expression. Arterioscler Thromb Vasc Biol 1999, 19:1105–1110.

    PubMed  CAS  Google Scholar 

  4. Kita T, Nagano Y, Yokode M, et al.: Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci (USA) 1987, 84:5928–5931.

    Article  CAS  Google Scholar 

  5. Carew T, Schwenke D, Steinberg D, et al.: Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low-density lipoprotein degradation in macrophagerich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci (USA) 1987, 84:7725–7729.

    Article  CAS  Google Scholar 

  6. Kita T, Nagano Y, Yokode M, et al.: Prevention of atherosclerotic progression in Watanabe rabbits on probucol. Am J Cardiol 1988, 62:13B.

    Google Scholar 

  7. Dujovne C, Harris W, Colle Gerrond L, et al.: Comparison of effects of probucol versus vitamin on ex vivo oxidation susceptibility of lipoproteins in hyperlipoproteinemia. Am J Med 1994, 74:38.

    CAS  Google Scholar 

  8. Nunes G, Sgoutas D, Redden R, et al.: Combination of vitamins C and E alters the response to coronary balloon injury in the pig. Arterioscler Thromb Vasc Biol 1995, 15:156–165.

    PubMed  CAS  Google Scholar 

  9. Tamminen M, Mottino G, Qiao J, et al.: Ultrastructure of early lipid accumulation in apoE-deficient mice. Arterioscler Throm Vasc Biol 1999, 19:847–853.

    CAS  Google Scholar 

  10. Nakashima Y, Plump A, Raines E, et al.: ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994, 14:133–140.

    PubMed  CAS  Google Scholar 

  11. Aburatani H, Matsumoto A, Kodama T, et al.: Increased levels of messenger ribonucleic acid for apolipoprotein E in the spleen of Probucol-treated rabbits. Amer J Cardiol 1988, 61:60B.

    Google Scholar 

  12. Singal P, Iliskovic N, Li T, et al.: Adriamycin cardiomyopathy: pathophysiology and prevention. FASEB J 1997, 11:931–936.

    PubMed  CAS  Google Scholar 

  13. Li L, Chen J, Liao D, et al.: Probucol inhibits oxidized-low density lipoprotein-induced adhesion of monocytes to endothelial cells by reducing P-selectin synthesis in vitro. Indothelium 1998, 6:18.

    CAS  Google Scholar 

  14. Hoshida S, Yamashita N, Igarashi J, et al.: Long-term probucol treatment reverses the severity of myocardial injury in Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol 1997, 17:2801–2807.

    PubMed  CAS  Google Scholar 

  15. Anderson TJ, Meredith IT, Yeung AC, et. al.: The effect of cholesterol-lowering and anti-oxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995, 332:488–493.

    Article  PubMed  CAS  Google Scholar 

  16. Inoue N, Ohara Y, Fukai T, et al.: Probucol improves endothelial-dependent relaxation and decreases vascular superoxide production in cholesterol-fed rabbits. Am J Med Sci 1998, 315:242–247.

    Article  PubMed  CAS  Google Scholar 

  17. Boger P, Bode-Boger S, Szuba A, et al.: Asymmetric dimethyl-arginine (adma): a novel risk factor for endothelial dysfunction, its role in hypercholesterolemia. Circulation 1998, 98:1842–1847.

    PubMed  CAS  Google Scholar 

  18. Bonsack M, Felemovicius I, Baptista M, et al.: Radioprotection of the intestinal mucosa of rats by probucol. Radation Res 1999, 151:69–73.

    Article  CAS  Google Scholar 

  19. Ito M, Suzuki Y, Ishihara M, et al.: Anti-ulcer efforts of antioxidants: effect of probucol. Eur J Pharmacol 1998, 354:189–196.

    Article  PubMed  CAS  Google Scholar 

  20. Yasunari K, Kohno M, Kano H, et al.: Antioxidants improve impaired insulin-mediated glucose uptake and prevent migration and proliferation of cultured rabbit coronary smooth muscle cells induced by high glucose. Circulation 1999, 99:1370–1378.

    PubMed  CAS  Google Scholar 

  21. Eddy AA: Interstitial fibrosis in hypercholesterolemic rats: role of oxidation, matrix synthesis, and proteolytic cascades. Kidney Intern 1998, 53:1182–1189.

    Article  CAS  Google Scholar 

  22. Li S, Forster L, Anggard E, et al.: RT-PCR study on the effects of minimally modified low-density lipoproteins and probucol treatment on gene expressions of interleukin-1 and platelet-derived growth factor b-chain in human peripheral blood mononuclear cells. Biol Signals 1966, 5:263–274.

    Google Scholar 

  23. Li S, Forster L, Anggard E, et al.: The effects of lps and probucol on interleukin i (il-1) and platelet-derived growth factor (pdgf) gene expression in the human monocytic cell line u-937. Biochemica et Biophysica Acta 1994, 1225:271–274.

    Article  CAS  Google Scholar 

  24. Akeson A, Woods C, Mosher L, et al.: Inhibition of il-ib expression in thp-1 cells by probucol and tocopherol. Atherosclerosis 1991, 86: 261–270.

    Article  PubMed  CAS  Google Scholar 

  25. Tanaka K, Hayashi K, Shingu T, et al.: Probucol inhibits neointiman formation in carotid arteries of normocholesterolemic rabbits and the proliferation of cultured rabbit vascular smooth muscle cells. Cardiovasc Drugs Ther 1998, 12:19–28.

    Article  PubMed  CAS  Google Scholar 

  26. Miyauchi K, Aikawa M, Tani T, et al.: Effect of Probucol on smooth muscle cell proliferation and dedifferentiation after vascular injury in rabbits: possible role of pdgf. Cardiovasc Drugs Ther 1998, 12:251–260.

    Article  PubMed  CAS  Google Scholar 

  27. Itoh H, Komori K, Okazaki J, et al.: The effect of Probucol on intimal thickening of autologous vein grafts in hyperlipidemic rabbit. Cardiovasc Surg 1997; 5:497.

    Article  PubMed  CAS  Google Scholar 

  28. Grafe M, Auch-Schwelk W, Hertel H, et al.: Human cardiac microvascular and macrovascular endothelial cells respond differently to oxidatively modified LDL. Atherosclerosis 1998, 137:87–95.

    Article  PubMed  CAS  Google Scholar 

  29. Baldasarre D, Franceschini G, Peruzzotti G, et al.: Clinical evaluation of probucol in hypercholesterolemia: individual lipoprotein responses and inhibitory effect on carotid atherosclerosis progression. J Cardiovasc Pharmacol 1997, 30:784–789.

    Article  Google Scholar 

  30. Tardil J-C, Cote G, Lesperance J, et al.: Probucol and multiviamins in the prevention of restenosis after coronary angioplasty. N Engl J Med 1997, 337:365–372.

    Article  Google Scholar 

  31. Yokoi H, Daida H, Kuwabara Y, et al.: Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the probucol angioplasty restenosis trial. J Amer Coll Cardiol 1997, 30:855–862.

    Article  CAS  Google Scholar 

  32. Sekiya M, Funada J, Watanabe K, et al.: Effects of probucol and cilostazol alone and in combination on frequency of poststenting restenosis. Amer J Cardiol 1998, 82:144–147.

    Article  PubMed  CAS  Google Scholar 

  33. Cote G, Tardif J-C, Lesperance J, et al.: Effects of Probucol on vascular remodeling after coronary angioplasty. Circulation 1999, 99:30–35.

    PubMed  CAS  Google Scholar 

  34. Lussier-Cacan S, Dubreuil-Quidoz S, Roederer G, et al.: Influence of probucol on enhanced LDL oxidation after fish oil treatment of hypertriglyceridemic patients. Arterioscler Thromb 1993, 13:1790–1797.

    PubMed  CAS  Google Scholar 

  35. Yamamoto A, Hara H, Takaichi S, et al.: Effect of probucol on macrophages, leading to regression of xanthomas and atheromatous vascular lesions. Amer J Cardiol 1988, 62:31B.

    Google Scholar 

  36. Oshima R, Ikeda T, Watanabe K, et al.: Probucol treatment attenuates the aortic atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Atherosclerosis 1998, 137:13–22.

    Article  PubMed  CAS  Google Scholar 

  37. Goldberg R, Mendez A: Probucol enhances cholesterol efflux from cultured human skin fibroblasts. Amer J Cardiol 1988, 62:57B.

    Google Scholar 

  38. Jiafu O, Keijiro S, Shiro J, et al.: Mechanism of action of probucol on cholesterolester transfer protein (CETP) mRNA in a Chinese hamster ovary cell line that had been stably transfected with a human CETP gene. Biochimica et Biophysica Acta 1998, 1393:153–160.

    Google Scholar 

  39. Barnhart J, Li D, Cheng W, et al.: Probucol enhances cholesterol transport in cultured rat hepatocytes. Amer J Cardiol 1988, 62:52B.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kansas Foundation for Clinical Pharmacology, Radiant Research, Kansas City, 10550 Quivira Road, Suite 220, 66215, Overland Park, KS, USA

    Karl D. Pfuetze MD & Carlos A. Dujovne MD

Authors
  1. Karl D. Pfuetze MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlos A. Dujovne MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pfuetze, K.D., Dujovne, C.A. Probucol. Curr Atheroscler Rep 2, 47–57 (2000). https://doi.org/10.1007/s11883-000-0094-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-000-0094-0

Keywords

Search

Navigation